Macitentan metabolite-d4
| CAT. No. | CP-IL0139 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C16H10D4Br2N6O4S |
| Mol. Wt. | 550.22 |
| Stock Status | Please Enquire |
- Synonyms: NA
- Chemical Name: N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide-d4
Request for Quotation : Macitentan metabolite-d4
Related Products
| CAT. No. | CP-M5004 |
|---|---|
| CAS. No. | 2211059-00-4 |
| Mol. F. | C19H21BrN6O4S |
| Mol. Wt. | 509.38 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-M5000 |
|---|---|
| CAS. No. | 441798-33-0 |
| Mol. F. | C19H20Br2N6O4S |
| Mol. Wt. | 588.27 |
| Stock Status: | In Stock |
| CAT. No. | CP-M5001 |
|---|---|
| CAS. No. | 2211059-05-9 |
| Mol. F. | C12H12BrN3O2 |
| Mol. Wt. | 310.15 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-M5002 |
|---|---|
| CAS. No. | 2211054-46-3 |
| Mol. F. | C10H8BrN3O |
| Mol. Wt. | 266.10 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-M5005 |
|---|---|
| CAS. No. | 149506-35-4 |
| Mol. F. | C11H11BrO4 |
| Mol. Wt. | 286.11 |
| Stock Status: | In Stock |
| CAT. No. | CP-M5006 |
|---|---|
| CAS. No. | 706811-25-8 |
| Mol. F. | C10H7BrN2O2 |
| Mol. Wt. | 267.08 |
| Stock Status: | In Stock |
| CAT. No. | CP-M5003 |
|---|---|
| CAS. No. | 146533-41-7 |
| Mol. F. | C10H5BrCl2N2 |
| Mol. Wt. | 303.977 |
| Stock Status: | In Stock |
| CAT. No. | CP-M5007 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C19H19Br2N7O5S |
| Mol. Wt. | 617.27 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-M5008 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C28H30Br2N10O8S2 |
| Mol. Wt. | 858.54 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-M5058 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C15H18BrN5O5S |
| Mol. Wt. | 460.30 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-M5049 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C13H13BrClN5O3S |
| Mol. Wt. | 434.69 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-M5011 |
|---|---|
| CAS. No. | 1393813-42-7 |
| Mol. F. | C13H14BrClN4O2S |
| Mol. Wt. | 405.70 |
| Stock Status: | In Stock |
